Literature DB >> 21168389

Octaarginine-modified liposomes enhance the anti-oxidant effect of Lecithinized superoxide dismutase by increasing its cellular uptake.

Ryo Furukawa1, Yuma Yamada, Mitsuko Takenaga, Rie Igarashi, Hideyoshi Harashima.   

Abstract

The anti-oxidant enzyme superoxide dismutase (SOD) has the potential for use as a therapeutic agent in the treatment of various diseases caused by reactive oxygen species. However, achieving this would be difficult without a suitable delivery system for SOD. We previously reported that PC-SOD, in which four molecules of a phosphatidylcholine (PC) derivative were covalently bound to each dimer of recombinant human CuZnSOD, was a high affinity for the cell membrane [14]. Here, we show that an octaarginine (R8) modified liposome equipped with PC-SOD (R8-LP (PC-SOD)) enhances its anti-oxidant effect. High-density R8-modified liposomes can stimulate macropinocytosis and are taken up efficiently by cells as demonstrated in a previous study [21]. Flow cytometry analyses showed that R8-LP (PC-SOD) was taken up by cells more efficiently than PC-SOD. Moreover, R8-LP (PC-SOD) liposomes were found to scavenge superoxide anions (O(2)(-)) very efficiently. These results suggest that the efficient cytosolic delivery of PC-SOD by R8-modified liposomes would enhance the anti-oxidant effects of PC-SOD.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168389     DOI: 10.1016/j.bbrc.2010.12.062

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer.

Authors:  Swati Biswas; Pranali P Deshpande; Federico Perche; Namita S Dodwadkar; Shailendra D Sane; Vladimir P Torchilin
Journal:  Cancer Lett       Date:  2013-02-16       Impact factor: 8.679

2.  Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition.

Authors:  Alexander Koshkaryev; Aleksandr Piroyan; Vladimir P Torchilin
Journal:  Cancer Lett       Date:  2012-06-25       Impact factor: 8.679

3.  MiR-125a regulates mitochondrial homeostasis through targeting mitofusin 1 to control hypoxic pulmonary vascular remodeling.

Authors:  Cui Ma; Chen Zhang; Mingfei Ma; Lixin Zhang; Linlin Zhang; Fengying Zhang; Yingli Chen; Fangyuan Cao; Minghui Li; Guangtian Wang; Tingting Shen; Hongmin Yao; Yumei Liu; Zhenwei Pan; Shasha Song; Daling Zhu
Journal:  J Mol Med (Berl)       Date:  2017-06-07       Impact factor: 4.599

4.  Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.

Authors:  Ling Yuan; Congyan Liu; Yan Chen; Zhenhai Zhang; Lei Zhou; Ding Qu
Journal:  Int J Nanomedicine       Date:  2013-11-05

Review 5.  Nanoantioxidants: Recent Trends in Antioxidant Delivery Applications.

Authors:  Ibrahim Khalil; Wageeh A Yehye; Alaitz Etxabide Etxeberria; Abeer A Alhadi; Seyedehsara Masoomi Dezfooli; Nurhidayatullaili Binti Muhd Julkapli; Wan Jefrey Basirun; Ali Seyfoddin
Journal:  Antioxidants (Basel)       Date:  2019-12-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.